Oliman, Bahira .

HRN: 19-48-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2025
CEFTRIAXONE 1G (VIAL)
06/27/2025
07/04/2025
IV
2g
OD
Sepsis
Waiting Final Action 
07/07/2025
MUPIROCIN 2%, 15G (TUBE)
07/07/2025
07/14/2025
TOPICAL
Apply On Trache Site
OD
Tracheostomy Site Care Prophylaxis
Remove - Pending Acceptance
07/11/2025
LEVOFLOXACIN 500MG (TAB)
07/11/2025
07/17/2025
PO
500mg
OD
Complicated Uti
Remove - Pending Acceptance
07/14/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/14/2025
07/20/2025
IVT
500mg
OD
Complicated UTI
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: